Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Ophthalmology Physician in Braintree, MA
NPI: 1134112188Primary Practice Location
Harvard Vanguard Medical Associates
111 Grossman Dr, Braintree, MA
Primary Employer
Atrius Health, Inc.
atriushealth.org
HQ Phone
Get M.D. Christopher's Phone Numberphone_androidMobile
Get M.D. Christopher's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
MA State Medical License
2005 - 2025
American Board of Ophthalmology
Ophthalmology
Boston University School Of Medicine
bumc.bu.edu
Medical School
Until 2001
Massachusetts Eye and Ear Infirmary/Harvard Medical School
Fellowship • Surgical Retina and Vitreous
2006 - 2008
Mass General Brigham/Massachusetts Eye and Ear/Harvard Medical School
Residency • Ophthalmology
2002 - 2006
Cambridge Health Alliance
Internship • Transitional Year
2001 - 2002
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92134Diagnostic imaging of retina | 113 | 222 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 96 | 112 |
| 3 | 67028Injection of drug into eye | 30 | 130 |
| 4 | J9035Injection, bevacizumab, 10 mg | 24 | 97 |
| 5 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 20 | 21 |
Authors: Deeba Husain, Lucia Sobrin, Maurice James, Ramak Roohipourmoallai
Journal: Graefes Arch Clin Exp Ophthalmol
Publication Date: 2016-09-15
Inherited proliferative vitreoretinopathies of childhood.
Authors: Andreoli, Christopher M, Warden, Scott M, Mukai, Shizuo
Journal: Int Ophthalmol Clin
Recognizing the protruding eye.
Authors: Peter Rubin, Lily Lin
Journal: Orbit
Lead Sponsor: ThromboGenics
Lead Sponsor: Paul Yates, MD, PhD
Collaborators: MEDARVA Foundation
Intervention / Treatment: DRUG: Placebo, DRUG: ORACEA®